- Home
- LSF vs ZYXI Comparison
LSF vs ZYXI Comparison
Compare LSF & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSF
- ZYXI
- Stock Information
- Founded
- LSF 2015
- ZYXI 1996
- Country
- LSF United States
- ZYXI United States
- Employees
- LSF N/A
- ZYXI N/A
- Industry
- LSF Packaged Foods
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- LSF Consumer Staples
- ZYXI Health Care
- Exchange
- LSF Nasdaq
- ZYXI Nasdaq
- Market Cap
- LSF 61.6M
- ZYXI 72.3M
- IPO Year
- LSF 2020
- ZYXI N/A
- Fundamental
- Price
- LSF $5.75
- ZYXI $1.48
- Analyst Decision
- LSF Strong Buy
- ZYXI Hold
- Analyst Count
- LSF 2
- ZYXI 3
- Target Price
- LSF $12.00
- ZYXI $3.00
- AVG Volume (30 Days)
- LSF 34.6K
- ZYXI 115.7K
- Earning Date
- LSF 11-05-2025
- ZYXI 10-23-2025
- Dividend Yield
- LSF N/A
- ZYXI N/A
- EPS Growth
- LSF N/A
- ZYXI N/A
- EPS
- LSF N/A
- ZYXI N/A
- Revenue
- LSF $47,027,546.00
- ZYXI $144,808,000.00
- Revenue This Year
- LSF $21.88
- ZYXI N/A
- Revenue Next Year
- LSF $20.86
- ZYXI $13.48
- P/E Ratio
- LSF N/A
- ZYXI N/A
- Revenue Growth
- LSF 22.79
- ZYXI N/A
- 52 Week Low
- LSF $3.60
- ZYXI $1.23
- 52 Week High
- LSF $10.90
- ZYXI $9.42
- Technical
- Relative Strength Index (RSI)
- LSF 43.26
- ZYXI 40.26
- Support Level
- LSF $5.68
- ZYXI $1.41
- Resistance Level
- LSF $5.99
- ZYXI $1.55
- Average True Range (ATR)
- LSF 0.25
- ZYXI 0.09
- MACD
- LSF 0.04
- ZYXI 0.02
- Stochastic Oscillator
- LSF 25.21
- ZYXI 20.59
About LSF Laird Superfood Inc.
Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.